Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PMPCAP1 ("PMPCA pseudogene 1") is a human genomic pseudogene derived from the PMPCA (peptidase, mitochondrial processing subunit alpha) gene[7][5]. Unlike the canonical PMPCA protein, which serves key mitochondrial functions in processing precursor proteins, PMPCAP1 does not encode a functional protein and is considered a noncoding or defective gene segment. Pseudogenes may sometimes have regulatory impacts in the genome, such as acting as miRNA decoys, but for PMPCAP1, there is no evidence of protein expression, clinical relevance, or biological function, nor is it considered a therapeutic target. The gene is categorized simply as a pseudogene in gene databases, with no annotated molecular or disease roles[7][5][6].
Not applicable; since there are no drugs targeting PMPCAP1, mechanisms of action do not exist.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PMPCA pseudogene 1 (PMPCAP1).